Reformulated version of FluMist influenza vaccine wins

FluMist, the only needle-free flu vaccine on the market, won a lukewarm recommendation from federal vaccine advisers Wednesday.
The nasal spray vaccine has been off the U.S. market for two years because it barely worked against one common strain of flu in kids. The company that makes it, MedImmune, says it has reformulated the vaccine and thinks it will work better next year.
“This is not an easy decision,” said Dr. Nancy Bennett, chair of the Advisory Committee on Immunization Practices (ACIP), whose decision guide which vaccines are available on the U.S. market.

Source:  nbcnews